More Cohesive Coverage-With-Evidence Authority Needed, Lawmakers Told
This article was originally published in The Gray Sheet
Executive Summary
Former CMS coverage chief Louis Jacques told House lawmakers that the agency’s authorities to implement coverage-with-evidence-development policies are fragmented, hindering application of the program.
You may also be interested in...
Louis Jacques On Coverage, Evidence And IDEs
In the first part of a two-part Q&A, just-departed CMS coverage director Louis Jacques talks about the strong future ahead he envisions for the Medicare coverage-with-evidence-development program and new coverage policies that will be implemented for investigational device exemption trials.
CMS Ambiguous On Role Of Local Contractors In Coverage With Evidence Development
Activities by Medicare contractors were among several matters that were addressed in CMS’ recent CED draft guidance that may not be fully clarified until the updated guidelines are put into practice, experts say.
Japan Grants Global-First Approval To Zolbetuximab, 15 Other New Drugs
Astellas's first-in class CLDN18.2-targeting antibody receives its first approval worldwide, while crovalimab and a number of drugs for rare diseases also receive nods from regulators and are now awaiting reimbursement price-listing.